Dr. Dianne Petrone, M.D.
What this data tells you about Dr. Petrone
Dr. Dianne Petrone is a rheumatology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Petrone performed 4,888 Medicare services across 1,466 unique beneficiaries.
Between the years covered by Open Payments, Dr. Petrone received a total of $507,934 from 53 pharmaceutical and/or device companies across 2151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Petrone is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,860 | $18 | $23 |
| Office visit, established patient (30-39 min) | 568 | $85 | $131 |
| Comprehensive metabolic blood panel | 430 | $10 | $14 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 419 | $4 | $5 |
| Complete blood count (CBC) with differential | 386 | $7 | $10 |
| C-reactive protein test (inflammation marker) | 334 | $5 | $7 |
| Blood draw (venipuncture) | 192 | $3 | $4 |
| Administration of chemotherapy into vein, each additional hour | 75 | $23 | $29 |
| Vitamin D level test | 73 | $29 | $30 |
| Administration of chemotherapy into vein, 1 hour or less | 61 | $105 | $136 |
| Complete blood count (CBC), automated | 44 | $6 | $6 |
| Thyroid stimulating hormone (TSH) test | 41 | $16 | $17 |
| Automated urinalysis | 39 | $2 | $2 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 33 | $58 | $79 |
| Vitamin B-12 level test | 31 | $15 | $16 |
| Folic acid level test | 30 | $14 | $16 |
| Bone density scan (DEXA) | 28 | $38 | $52 |
| Ferritin level test (iron stores) | 25 | $13 | $14 |
| Iron level test | 23 | $6 | $6 |
| Thyroxine (thyroid chemical), total | 23 | $7 | $7 |
| Thyroid hormone evaluation | 23 | $6 | $6 |
| Iron binding capacity test | 22 | $9 | $9 |
| New patient office visit, complex (60-74 min) | 21 | $174 | $222 |
| Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | 18 | $32 | $41 |
| Measurement of complement (immune system proteins), antigen, | 17 | $12 | $12 |
| Measurement of complement function (immune system proteins) | 17 | $12 | $12 |
| Office visit, established patient (20-29 min) | 17 | $59 | $92 |
| Urinalysis with microscopic exam | 14 | $3 | $3 |
| Creatine kinase (cardiac enzyme) level, total | 13 | $6 | $7 |
| Flu vaccine administration | 11 | $15 | $19 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for rheumatology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Petrone is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Petrone experienced with denosumab injection (prolia/xgeva)?
Does Dr. Petrone receive payments from pharmaceutical companies?
How do Dr. Petrone's costs compare to other rheumatologists in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology